STOCK ALARM
SA
Menu
⌘K
Set Alert
Demo
Log In
Today
My Portfolio
Find Stocks
The Market
Charts
Research
Advisor
⌘J
JUBLPHARMA.NS
(JUBLPHARMA.NS)
JUBLPHARMA.NS
Overview
Intelligence
Chart
Fundamentals
Key Metrics
Earnings
Growth
Analysts
Financials
Insiders
Institutional
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
JUBLPHARMA.NS
(JUBLPHARMA.NS)
$930.50
▲
3.65 (39.38%)
Chart
Share
Post on X
JUBLPHARMA.NS
JUBLPHARMA.NS
(JUBLPHARMA.NS)
NSE
$930.50
▲
3.65 (39.38%)
Chart Studio
Share
JUBLPHARMA.NS
Show Technical Panel
Show S&P 500 Navigator
Loading chart...
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$145.64B
+59.8%
P/E Ratio
17.35
-85.3%
P/S Ratio
2.01
+48.0%
ROE
13.42%
+845.8%
ROIC
18.37%
+107.9%
FCF Yield
-0.30%
-137.0%
Debt/Equity
0.44
-35.2%
Current Ratio
1.65
-19.5%
Interest Coverage
9.80x
+29.3%
Per Share
Revenue/Share
$455.50
+7.8%
Net Income/Share
$52.85
+987.4%
Operating CF/Share
$67.50
+10.2%
Free CF/Share
$-2.74
-159.0%
Cash/Share
$68.55
+14.0%
Book Value/Share
$392.79
+14.9%
Tangible Book/Share
$163.76
+35.7%
Equity/Share
$393.82
+15.0%
Interest Debt/Share
$187.08
-24.6%
Valuation
Market Cap
$145.64B
+59.8%
Enterprise Value
$162.07B
+37.0%
P/E Ratio
17.35
-85.3%
P/S Ratio
2.01
+48.0%
P/OCF Ratio
13.58
+44.8%
P/FCF Ratio
-334.81
-370.3%
P/B Ratio
2.33
+38.8%
P/TB Ratio
2.33
+38.8%
EV/Sales
2.24
+27.0%
EV/EBITDA
15.47
+3.8%
Profitability
Earnings Yield
5.76%
+581.4%
FCF Yield
-0.30%
-137.0%
ROE
13.42%
+845.8%
ROIC
18.37%
+107.9%
Return on Tangible Assets
9.21%
+860.1%
Capital Allocation
CapEx/OCF
104.06%
+12.6%
CapEx/Revenue
15.42%
+15.1%
CapEx/Depreciation
3.03
+28.8%
SBC/Revenue
0.06%
-53.1%
Balance Sheet
Debt/Equity
0.44
-35.2%
Debt/Assets
0.21
-32.5%
Net Debt/EBITDA
1.57
-54.1%
Current Ratio
1.65
-19.5%
Interest Coverage
9.80x
+29.3%
Income Quality
1.28
-89.9%
Efficiency
Days Sales Outstanding
45 days
-33.9%
Days Payables Outstanding
145 days
+8.8%
Days Inventory
163 days
-19.7%
Receivables Turnover
8.10x
+51.3%
Payables Turnover
2.52x
-8.1%
Inventory Turnover
2.25x
+24.5%
Special Valuations
Graham Number
$684.32
+253.6%
Graham Net-Net
$-264.12
-16.9%